Results 151 to 160 of about 8,720 (195)
Some of the next articles are maybe not open access.
The pharmacology of cilostazol
Diabetes, Obesity and Metabolism, 2002Cilostazol (6‐[4‐(1‐cyclohexyl‐ 1H ‐tetrazol‐5‐yl)butoxy]‐3,4‐dihydro‐2(1 H )‐quinolinone; OPC‐13013) is a 2‐oxo‐quinoline derivative with antithrombotic, vasodilator, antimitogenic and cardiotonic properties.
exaly +3 more sources
Drugs & Aging, 1999
Cilostazol is an antiplatelet agent with vasodilating properties that has been used in the treatment of patients with peripheral ischaemia such as intermittent claudication. The drug inhibits platelet aggregation induced by ADP, collagen and arachidonic acid.
E M, Sorkin, A, Markham
+6 more sources
Cilostazol is an antiplatelet agent with vasodilating properties that has been used in the treatment of patients with peripheral ischaemia such as intermittent claudication. The drug inhibits platelet aggregation induced by ADP, collagen and arachidonic acid.
E M, Sorkin, A, Markham
+6 more sources
Heart disease (Hagerstown, Md.), 2002
Cilostazol is a phosphodiesterase III inhibitor that has been shown to be effective for treatment of symptomatic intermittent claudication. It is generally well tolerated, but is contraindicated in patients with severe heart failure because of the potential detrimental effects demonstrated by other agents in the same class.
+7 more sources
Cilostazol is a phosphodiesterase III inhibitor that has been shown to be effective for treatment of symptomatic intermittent claudication. It is generally well tolerated, but is contraindicated in patients with severe heart failure because of the potential detrimental effects demonstrated by other agents in the same class.
+7 more sources
Cilostazol in the Management of Atherosclerosis
Current Vascular Pharmacology, 2010The burden of atherosclerosis is particularly high in western countries in terms of mortality and disability. The cerebral arteries (stroke or transient ischemic attack [TIA]), coronary arteries (myocardial infarction [MI]) and peripheral arteries (intermittent claudication [IC], ischemic limb) can be affected.
Sallustio F +3 more
openaire +3 more sources